Akebia Therapeutics Receives $41,000,000 Series C Round

  • Feed Type
  • Date
    6/5/2013
  • Company Name
    Akebia Therapeutics
  • Mailing Address
    9987 Carver Rd. Cincinnati, OH 45242
  • Company Description
    Akebia Therapeutics is a venture-backed start-up pharmaceutical company with a focus on treatments for ischemia and improvement of vascular disease.
  • Website
    http://www.akebia.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $41,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The proceeds of this financing will be used to fund the ongoing development of AKB-6548, the Company’s lead clinical compound.
  • M&A Terms
  • Venture Investor
    Satter Investment Management
  • Venture Investor
    Novartis Venture Fund
  • Venture Investor
    Kearny Venture Partners
  • Venture Investor
    Venture Investors
  • Venture Investor
    Athenian Venture Partners
  • Venture Investor
    Triathlon Medical Ventures
  • Venture Investor
    AgeChem Venture Fund
  • Venture Investor
    Sigvion Capital

By posting a comment, you agree to our terms and conditions.